supplied by www.ccc.ac.at

4 Einträge

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Autoren Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A
Erscheinungsdaten The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9
Publikations ID PMID: 29146401
 


Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue.
Autoren Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ
Erscheinungsdaten Journal of clinical apheresis. doi: 10.1002/jca.21705
Publikations ID PMID: 31180581
 


PET-MR and SPECT-MR multimodality probes: Development and challenges.
Autoren Yang CT, Ghosh KK, Padmanabhan P, Langer O, Liu J, Eng DNC, Halldin C, Gulyás B
Erscheinungsdaten Theranostics. 2018 Nov 29. doi: 10.7150/thno.26610. pii: thnov08p6210. pmc: PMC6299694
Publikations ID PMID: 30613293
 


Bimodality Probes of Gd Enhanced T1-Weighted Magnetic Resonance/Optical Imaging.
Autoren Yang CT, Hattiholi A, Selvan ST, Yan SX, Fang WW, Chandrasekharan P, Koteswaraiah P, Herold CJ, Gulyás B, Aw SE, He T, Ng DCE, Padmanabhan P
Erscheinungsdaten Acta biomaterialia. 2020 Apr 23. pii: S1742-7061(20)30188-4. doi: 10.1016/j.actbio.2020.03.047
Publikations ID PMID: 32335310